Loading
A government or charity holds stocks of experimental cancer drugs under standing agreements, so academic doctors can test combinations without negotiating with each company separately.
NCI's CTEP investigational agent programme has run for decades but covers a narrow set of agents and mostly US sites. A broader, international formulary of investigational and newly approved agents held under pre-agreed terms (including pricing for trial use of approved drugs) would let cooperative groups design combination trials from a menu rather than by bilateral pleading.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test, National Cancer Institute (NIH).
Shares Secrecy and intellectual property block collaboration, SWOG Cancer Research Network, Too many combinations to test.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.
Shares Secrecy and intellectual property block collaboration, Too many combinations to test.
Shares ECOG-ACRIN Cancer Research Group, National Cancer Institute (NIH).